Colorectal Cancer Microsatellite-stable
📧 Sign up to get email alerts when something new happens for Colorectal Cancer Microsatellite-stable.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer [Phase 1]
A Phase 1 study evaluating the combination of PolyPEPI1018 vaccine and TAS-102 in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of Azacitidine and Durvalumab in Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating azacitidine with durvalumab in advanced solid tumors has completed enrollment with conditions including microsatell…